Laura Snyder, MD
Retina Specialist · Raleigh, NCNPI 1205193208
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,578 of the $4,891 with a category attached, or 73.1%. 18 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 25.9% of the total.
Across 103 payments — averaging $47.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$947
- Genentech USA, Inc.$548
- AbbVie$518
- Alcon$358
- Harrow Eye, LLC$184
- plus $1K from 12 others
Across 3 payments — averaging $3366.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$10K
What the payments were for
- Travel & lodging$251%
- Food & beverage$3,57873%
- Gifts$190%
- Other$1,26926%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 1 | $1,269 |
| Regeneron Healthcare Solutions, Inc. | 23 | $947 |
| Genentech USA, Inc. | 19 | $548 |
| AbbVie(2 entities) | 25 | $518 |
| Alcon | 3 | $358 |
| Harrow Eye, LLC | 3 | $184 |
| Astellas Pharma US Inc | 6 | $173 |
| Novartis | 3 | $146 |
| Regeneron | 1 | $140 |
| Apellis Pharmaceuticals, Inc. | 7 | $135 |
| Genentech, Inc. | 1 | $116 |
| Alimera Sciences, Inc. | 3 | $109 |
| Ocular Therapeutix, Inc. | 1 | $89 |
| Stryker | 2 | $62 |
| Bausch & Lomb Americas Inc. | 2 | $37 |
| Eyepoint US, Inc. | 1 | $21 |
| Biogen | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,891 in reported general payments places this provider in the 60th percentile of 34 retina specialist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 212 | $10,581 |
| ValacyclovirValacyclovir Hcl | 35 | $1,080 |
| Brimonidine Tartrate | 12 | $840 |
| Tobramycin | 148 | $769 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 33 | $396 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 32 | $355 |
| Timolol Maleate | 29 | $268 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $162 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $77 |
| Methylprednisolone | 12 | $67 |
| Latanoprost | 12 | $52 |
| Ondansetron Hcl | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Raleigh
- Daniel BennettRaleigh$126K
- Raynor CaseyRaleigh$34K
- Sachin MudvariRaleigh$33K
- John ThordsenRaleigh$33K
- John DennyRaleigh$31K
- Rebecca ManningRaleigh$9K
- Lekha DesaiRaleigh$3K
- Brian LehpamerRaleigh$3K
- Eugene MilderRaleigh$2K
- Lisa FogelRaleigh$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.